NCT06084715

Brief Summary

Undernutrition is a leading global risk factor of tuberculosis (TB) and a prevalent comorbidity associated with TB. In Benin, the National TB Program systematically provides nutritional support to all persons with TB (PWTB), distributing prepared foods to hospitalized patients and food baskets during outpatient care. In Togo, the PWTB population is similar to that of Benin; however, Togo does not have a systematic program in place to provide nutritional support to these patients. The investigators will perform a prospective cohort analysis using anonymized TB patient data from the National TB Programs of Benin and Togo. Participants enrolled in Benin will receive nutritional support from the hospital while those enrolled in Togo will not. Participants in Togo who do not receive nutritional support will serve as a control. Unfavorable outcomes in both groups such as treatment failure, death, or relapse will be compared. The results from this study should help to shape TB programs in the future by incorporating nutritional support.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
769

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 7, 2023

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

October 5, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 16, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2025

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2025

Completed
Last Updated

November 17, 2025

Status Verified

November 1, 2025

Enrollment Period

2 years

First QC Date

October 5, 2023

Last Update Submit

November 14, 2025

Conditions

Keywords

Persons with TB (PWTB)Nutritional supportRepublic of BeninTogolese RepublicTreatment failureTB relapseChronic obstructive pulmonary disease (COPD)Quality of life

Outcome Measures

Primary Outcomes (1)

  • Percent of participants with an unfavorable outcome

    An unfavorable outcome will be a composite of TB treatment failure, death, or relapse based on patient evaluation 6 months after treatment completion.

    12 months

Secondary Outcomes (1)

  • Number of participants with failure of sputum conversion

    2 months

Other Outcomes (1)

  • Number of participants lost to follow up during therapy

    6 months

Study Arms (2)

Nutritional support group

Participants in this group will be enrolled in Benin and will receive nutritional support from the hospital where they receive care. They will be followed for 12 months.

Other: Nutritional support

Standard of care group

Participants in this group will be enrolled in Togo and will not receive nutritional support from the hospital where they receive care. They will be followed for 12 months.

Interventions

The hospitals in Benin already provide nutritional support for patients with pulmonary TB which will continue throughout the study.

Nutritional support group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1050 participants will be enrolled and followed for approximately 12 months. 700 will be enrolled in Benin and 350 in Togo. Participants enrolled in Benin will receive nutritional support from the hospital while those enrolled in Togo will not.

You may qualify if:

  • Drug susceptible, Xpert \[polymerase chain reaction (PCR) test for TB\] positive and/or sputum stain positive for AFB (≥1+)
  • Willing to attend follow-up visits and undergo study procedures

You may not qualify if:

  • Drug resistant TB
  • Has received 7 or more days of antimicrobial therapy
  • Based on study staff observation, the participant is too sick to enroll. Defined as a score of 4 on the World Health Organization (WHO) Performance assessment.
  • Pregnancy at the time of enrollment
  • Individuals who are unable to participate in the 6-minute walk test due to pre-existing mobility issues due to disability, trauma, neurological compromise, or cardiopulmonary issues

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier et Universitaire de Pneumo-phtisiologie

Porto-Novo, Benin

Location

National Tuberculosis Programme

Lomé, Togo

Location

Related Publications (1)

  • Cintron C, Dauphinais M, Fiogbe AA, Dogo MF, Ate S, Adjonou C, Agossou K, Pan SJ, Esse M, Ade B, Adjoh KS, Affolabi D, Sinha P, Koura KG. Impact of Nutritional Support for Tuberculosis on Intermediate and Terminal Undernutrition and Treatment Outcomes (INSTITUT) study: a protocol for a quasi-experimental study to assess the impact of nutritional support on tuberculosis treatment outcomes in Benin and Togo. BMJ Open. 2025 Feb 10;15(2):e088629. doi: 10.1136/bmjopen-2024-088629.

MeSH Terms

Conditions

Tuberculosis, PulmonaryMalnutritionPulmonary Disease, Chronic Obstructive

Interventions

Nutritional Support

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesNutrition DisordersNutritional and Metabolic DiseasesLung Diseases, ObstructiveChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Pranay Sinha, MD

    Boston Medical Center

    PRINCIPAL INVESTIGATOR
  • Kobto G Khoura, MD, PhD

    The International Union Against Tuberculosis and Lung Disease

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2023

First Posted

October 16, 2023

Study Start

September 7, 2023

Primary Completion

September 10, 2025

Study Completion

September 21, 2025

Last Updated

November 17, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations